Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Navamedic ASA ( (DE:N1A) ) has shared an update.
Navamedic ASA has announced the approval of a prospectus by the Financial Supervisory Authority of Norway for a rights issue aimed at raising between NOK 110 million and NOK 130 million. This move, which involves the listing of up to 6,046,511 offer shares on the Oslo Stock Exchange, is expected to strengthen the company’s financial position and enhance its market presence.
More about Navamedic ASA
Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. The company leverages its scalable market access platform and local knowledge to meet specific medical needs across the Nordic countries, the Baltics, Benelux, and Greece. Navamedic is headquartered in Oslo, Norway, and is listed on the Oslo Stock Exchange.
Average Trading Volume: 18,466
Current Market Cap: NOK516.9M
Learn more about N1A stock on TipRanks’ Stock Analysis page.